GeneTex has supported the world's leading researchers for over 15 years with our quality antibodies. Our products continue to be referenced in leading publications and we are proud to be able to contribute to the research community. In this GeneTex newsletter issue, we would like to highlight our catalog of Influenza Type A antibodies.
There are three types of influenza virus: Types A, B, and C. The influenza A and B viruses are the ones most associated with serious human infections, while the Type C cases are clinically much milder. The main antigenic determinants of influenza A and B viruses are the haemagglutinin (HA) and neuraminidase (NA) transmembrane glycoproteins. Based on the antigenicity of these glycoproteins, influenza A viruses are further subdivided into sixteen “H” (H1-H16) and nine “N” (N1-N9) subtypes. The influenza A virus genome consists of eight separate RNA segments that encode the proteins (i.e., PB1, PB2, PA, HA, NA, NP, M1, M2, NS1, and NS2) essential for host infection, viral genome replication, and virus particle packaging.
Influenza antibodies are not only important tools for basic research, but also for clinical diagnosis, vaccine development, and evaluation of anti-influenza therapeutics.GeneTex offers a panel of Influenza A antibodies of high sensitivity and specificity. Please see below to learn more about these antibodies and consider whether these reagents can accelerate your influenza research. To see our complete listing of related products, visit our website at www.genetex.com.